- Diagnostic Value of Combining Tumor and Inflammatory Markers in Lung Cancer
-
Yoon HI, Kwon OR, Kang KN, Shin YS, Shin HS, Yeon EH, Kwon KY, Hwang I, Jeon YK, Kim Y, Kim CW
- KMID: 2367569
- J Cancer Prev.
- 2016 Dec;21(4):302-302.
- doi: 10.15430/JCP.2016.21.4.302
In Table 2 and 3, cutoff values of RANTES, ApoA2, TTR, Svcam-1 (and sensitivity and specificity values accordingly) were wrongly marked. -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnostic Value of Combining Tumor and Inflammatory Markers in Lung Cancer
-
Yoon HI, Kwon OR, Kang KN, Shin YS, Shin HS, Yeon EH, Kwon KY, Hwang I, Jeon YK, Kim Y, Kim CW
- KMID: 2367577
- J Cancer Prev.
- 2016 Sep;21(3):187-193.
- doi: 10.15430/JCP.2016.21.3.187
BACKGROUND: Despite major advances in lung cancer treatment, early detection remains the most promising way of improving outcomes. To detect lung cancer in earlier stages, many serum biomarkers have been... -
- CITED
-
- Close
- SHARE
-
- Close
